TCI Wealth Advisors, Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2022$2,816
+181.6%
1,246
+290.6%
0.00%
Q3 2022$1,000
-50.0%
319
-37.5%
0.00%
Q2 2022$2,000
-75.0%
510
-13.7%
0.00%
-100.0%
Q4 2021$8,000591
+2173.1%
0.00%
Q3 2021$0
-100.0%
26
-86.5%
0.00%
-100.0%
Q2 2021$3,000
+200.0%
192
+638.5%
0.00%
Q1 2021$1,000260.0%0.00%
Q4 2020$0
-100.0%
26
-91.4%
0.00%
-100.0%
Q3 2020$5,000
-28.6%
3010.0%0.00%
-33.3%
Q2 2020$7,000
+133.3%
301
+84.7%
0.00%
+200.0%
Q1 2020$3,000
-40.0%
163
-28.5%
0.00%
-50.0%
Q4 2019$5,000
+25.0%
2280.0%0.00%0.0%
Q3 2019$4,000
-60.0%
228
-17.1%
0.00%
-60.0%
Q2 2019$10,000
+25.0%
275
+13.6%
0.01%
+25.0%
Q1 2019$8,0000.0%242
+5.7%
0.00%0.0%
Q4 2018$8,000
-38.5%
229
+6.0%
0.00%
-20.0%
Q3 2018$13,000
+44.4%
216
+12.5%
0.01%
+25.0%
Q2 2018$9,000
-55.0%
1920.0%0.00%
-55.6%
Q1 2018$20,000
+81.8%
1920.0%0.01%
+80.0%
Q4 2017$11,000
+120.0%
1920.0%0.01%
+150.0%
Q3 2017$5,000
+25.0%
1920.0%0.00%0.0%
Q2 2017$4,000
-20.0%
1920.0%0.00%
-33.3%
Q1 2017$5,000
+150.0%
1920.0%0.00%
+200.0%
Q4 2016$2,0001920.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders